MwanzoOGN • NYSE
add
Organon & Co
Bei iliyotangulia
$ 16.00
Bei za siku
$ 15.75 - $ 16.10
Bei za mwaka
$ 13.87 - $ 23.10
Thamani ya kampuni katika soko
4.08B USD
Wastani wa hisa zilizouzwa
3.97M
Uwiano wa bei na mapato
3.14
Mgao wa faida
7.07%
Ubadilishanaji wa msingi
NYSE
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.58B | 4.15% |
Matumizi ya uendeshaji wa biashara | 533.00M | -21.04% |
Mapato halisi | 359.00M | 518.97% |
Kiwango cha faida halisi | 22.69 | 493.98% |
Mapato kwa kila hisa | 0.87 | 0.00% |
EBITDA | 459.00M | 56.66% |
Asilimia ya kodi ya mapato | -73.43% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 763.00M | 84.30% |
Jumla ya mali | 12.75B | 15.80% |
Jumla ya dhima | 12.26B | 5.67% |
Jumla ya hisa | 493.00M | — |
hisa zilizosalia | 257.54M | — |
Uwiano wa bei na thamani | 8.38 | — |
Faida inayotokana na mali | 7.83% | — |
Faida inayotokana mtaji | 10.81% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 359.00M | 518.97% |
Pesa kutokana na shughuli | 141.00M | -45.98% |
Pesa kutokana na uwekezaji | -75.00M | -36.36% |
Pesa kutokana na ufadhili | -78.00M | 0.00% |
Mabadiliko halisi ya pesa taslimu | 59.00M | -32.95% |
Mtiririko huru wa pesa | 29.00M | -85.07% |
Kuhusu
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but gets a third of its revenue from the United States. Wikipedia
Ilianzishwa
2020
Makao Makuu
Tovuti
Wafanyakazi
10,000
